Target intelligence / Profile preview

Heparan sulfate proteoglycans and N-linked sialic acid-containing glycans (HSPG/Sialic acid glycans)

Target
HSPG/Sialic acid glycans
Molecular classification
Receptor, Other
01

Overview

Heparan sulfate proteoglycans (HSPGs) and N-linked sialic acid-containing glycans are complex carbohydrate-containing molecules located on the surface of almost all mammalian cells. HSPGs consist of a core protein with attached heparan sulfate glycosaminoglycan chains, while N-linked sialic acid glycans are oligosaccharides attached to proteins via asparagine residues, ending in sialic acid. These molecules serve as critical attachment receptors or co-receptors for a wide variety of viruses, including Influenza, SARS-CoV-2, and Adeno-associated viruses (AAV), by facilitating the initial docking of the pathogen to the host cell. Beyond viral entry, they play fundamental roles in cell-cell signaling, basement membrane integrity, and the regulation of growth factor activity. Therapeutic targeting of these glycans involves the use of mimetics to competitively inhibit viral binding or enzymes like sialidases to remove the glycan receptors from the cell surface. However, due to their ubiquitous nature and essential roles in physiology, drugs targeting these molecules must be carefully designed to avoid interfering with normal cellular processes such as blood coagulation and tissue repair.

Other names
HSPGsSialylated glycansViral attachment receptorsCell surface glycocalyx components
02

Mechanism of action

Viral entry inhibition, Competitive binding to attachment factors, Enzymatic cleavage of cell surface glycans

03

Biological functions

Cell adhesionViral attachmentSignal transductionGrowth factor sequestrationExtracellular matrix organization
04

Disease associations

InfectionCancerInflammationCystic fibrosis
05

Safety considerations

Disruption of homeostatic signalingAnticoagulant effectsImpaired wound healingSystemic toxicity due to ubiquitous expression
06

Interacting drugs

Heparin

5 more in the full profile.

07

Biomarkers

Heparan sulfate sulfation patternsSialic acid expression levelsGlycan density on cell surfaceNeuraminidase activity

Beyond the preview

Go deeper on Heparan sulfate proteoglycans and N-linked sialic acid-containing glycans (HSPG/Sialic acid glycans).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heparan sulfate proteoglycans and N-linked sialic acid-containing glycans (HSPG/Sialic acid glycans).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call